Filed in archive
Corporate and Industrial News
by ruth on April 17, 2007

- Alliances involving US companies reached 23 bln usd, an all time high.
- Capital raised by the worlds biotechnology companies surged 42 pct to 27.9 bln usd.
- Venture capital reached 5.4 bln usd, an all-time high.
- Global public company revenues grew by double-digit rates and crossed the 70 bln usd threshold for the first time.
- Double-digit revenue growth was achieved in Canada, the US and in Europe.
- The European biotech sector sustained its recovery of 2005, with 2006 marking a four-year Turnaround.
'The industry in the US has never been stronger and were seeing its success story spreading to other parts of the worldparticularly Europe, said Glen Giovannetti, Ernst & Youngs Global Biotechnology Leader.
You can download the E&Y reports here:
Biotech Industry Overview and 2005 Year in Review (pdf, 210kb)
Americas Biotech: Strength and Stability (pdf, 198kb)
European Biotech: Back on Track (pdf, 200kb)
Asia-Pacific Biotech: Emerging Focus (pdf, 163kb)
Permalink: Biotech Showed Robust Growth in 2006
Tags:
biotech
biotechnology
investment
ernst+young
growth
biotech+showed
robust+growth
showed+robust
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/64063
Mr Wong
Vote for Biotech Showed Robust Growth in 2006:
|
Rating: 8.50 out of 2 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







